Margaret A. Alexander serves as Executive at Ovid Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Margaret A. Alexander has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 4, 2026 involved receiving (via award) 890,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 4, 2026 | OVID | $0 | Award | 890,000 | $N/A | Discretionary |
Margaret A. Alexander currently holds 890,000 shares of Ovid Therapeutics Inc. (OVID), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Margaret A. Alexander has been a net neutral trader of OVID stock. They have purchased $0 and sold $0 worth of shares.
Margaret A. Alexander's most recent insider trade was on Jan 4, 2026, when they sold 890,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted